Asset Management Corp T2 Biosystems, Inc. Transaction History

Asset Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	BUY	$0.09 - $565.0 $12,150 - $76.3 Million	135,000 New	135,000 $15,000
Q4 2021 Jan 25, 2022	SELL	$0.46 - $0.94 $8,122 - $16,598	-17,658 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$1.32 - $3.79 $52,591 - $151,001	-39,842 Reduced 69.29%	17,658 $29,000
Q4 2020 Jan 29, 2021	BUY	$1.06 - $1.51 $60,950 - $86,825	57,500 New	57,500 $104,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $5.99M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Asset Management Corp , based on Form 13F filings with the SEC.

Stay updated on Asset Management Corp with notifications on news.